Sentences with phrase «than program driven»

We as a congregation do invite people to church, but it is more from a relational drive rather than program driven.

Not exact matches

After all, the average car on American highways and byways is now more than 9 years old after a tough downturn that has driven home the virtue of making do, says John Paul, a spokesman for AAA of Southern New England and host of the «Car Doctor,» a weekly radio program.

The system makes a determination such as if people are tweeting about a program more than a competing show, how many people those posts and tweets reach, what people are saying about a program, if the program is driving an action like making people visit a website, and much more.

So rather than storing compressed, encrypted, fully indexed versions of entire hard drives, they can store individual objects and files that load much faster and are easily accessible by software programs.

More than 16,000 associates have joined since its inception with roughly three - fourths of the employees residing in the U.S. Commercial truck driving, health care, and information technology are the program's most popular fields of study, Bezos noted in the letter.

Nevertheless, Khosrowshahi remains optimistic about the future of the program, asserting that «ultimately, self - driving cars will be safer than humans,» but that right now, they're more like «student drivers.»

The following teams report to me - Contact Center Operations, Roadside Assistance, Network Training, Customer Experience & Loyalty Programs, Customer Insights & Reporting and CRM Systems - and through them I am able to drive our ability to delivering a better customer experience today than we did yesterday.

Most other Internet - sharing software programs, known as proxy servers, require users to reconfigure many of their computers» applications so that the machines can run off the proxy rather than the original hard drive.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Satwani — who hasn't delivered the CAR - T therapy but is heading up the program at Columbia, one of the 32 sites Novartis will use — said patients would need to be monitored closely for about a month, meaning they'd need to be less than a two - hour drive from their hospital.

The metric of «cash flow from operations as a percentage of revenue» has been used for more than five years as a financial metric in HP's long - term incentive programs, and HP believes that it continues to be a key metric that both drives and demonstrates improved financial performance within the company.

According to the Netflix gurus, «75 percent of viewer activity is driven by recommendations,» they use a team of «more than 40» freelance TV and movie experts who hand - tag every piece of programming available, and they know everything you do within Netflix.

This drives the cost to the tax payer up much more than a universal health care program that would treat everyone fairly by private physicians and use the more expensive emergency rooms for emergencies as they were intended.

The previous year he had been the hardest grinder on the Browns, arriving first for the off - season conditioning programs and leaving last, but now he was grimmer and more fiercely driven than ever.

I'm only just starting this one, but I can already see that it's more social - history - driven than Free for All, including some fascinating insights on how such seemingly far - flung issues as race, desegregation and gender have played into the development of the current school lunch program.

People driving regular passenger vehicles who had an E-ZPass enrolled in the program would pay $ 5.50 to cross, Previously, drivers who crossed the bridge more than three times a month paid $ 6, and those who crossed less paid $ 6.36.

Since RGGI was launched seven years ago, the program has collected more than $ 925 million from power plant owners to cover greenhouse gas emissions that drive climate change.

More than 150 children from the Fort George Community Enrichment Center's Head Start program were treated to a selection of Transformers and Barbie dolls Monday as part of a local toy drive.

The plan is to enroll a total of more than 3,000 drivers in six different states in what's called the Strategic Highway Research Program's Naturalistic Driving Study.

He assured his audience that «the mainstay» will be the individual investigator; anybody who thinks otherwise «need look no further» than the genome institute's intramural program, where research is «driven by ideas» and where he will keep his lab.

Until their vehicle program was eliminated in 2005, the folks at Langley Research Center planned to roll out three prototypes in sequence: a small prop plane that would tuck its wings in on the highway (it shouldn't cost any more than a Mercedes - Benz); a two - seater with rear - propeller drive; and, for tight parking spots, one capable of vertical takeoff.

Conservative critics say New Jersey's solar success is driven by government programs, including a renewable portfolio standard that requires utilities to derive more than 20 percent of their electricity from clean sources.

According to two new studies presented by researchers at the 2015 American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP ®) National Conference in Chicago, ACS NSQIP provides more accurate data than administrative data for driving surgical quality improvement in hospitals.

The relative decline in winter wheat acreage from 1987 - 2000 was probably driven more by the Conservation Reserve Program (CRP) than by direct climate effects.

However, it remains possible that the great success of the programs used by these teams might be driven more by the more extreme use of anabolic androgenic steroids (AAS) compared with other teams than by the specific training methods used (Fair, 1988; Franke & Berendonk, 1997; Storey & Smith, 2012).

by Walter Chaw A homoerotic cock - opera showing the sad and pathetic multiplicity of forms that mid-life crises can take, Driven, Renny Harlin's ode to thick necks and macho poses, is more «programmed» than «directed.»

Despite having spell check, a dictionary and legible text, the type - driven structure of a word processing program created a new layer of issues rather than supports.

According to a recent report, five studies have shown that farm - to - school meals generally cost more to prepare than conventional fare but typically increase student participation in meals programs, which drives up revenue.

To this end, the input - based metric of weekly student access to the learning plan ought to be removed, not because it is bad per se, but because it is more likely to encourage compliance - driven plans rather than thoughtful ones based on a coherent program.

What a school actually does — and how it performs its role to help children learn — rather than broad assumptions about the correct size, instructional program or governance model, should drive our efforts to ensure that these public schools are helping children succeed.

NextGen LMSs are driven by data, making it easier than ever for L&D teams to measure the success of the onboarding programs and see what is or isn't working.

The difference between his vision and AmeriCorps, however, was that Match volunteers would be singularly focused (more than most AmeriCorps programs) on driving student achievement up in a measurable way.

Rather than trying to compel equity of access through regulations that instead drive schools out of the program, we should incentivize equity by having student - weighted voucher amounts.

Rather than declaring victory, some in the early childhood community have responded to this growing consensus with an increased focus on using innovation to drive more effective policies and programs.

The Problem of Head Start Nowhere is resistance to structured, curriculum - based, standards - and - assessment - driven early education clearer than in the big, iconic, federal early - childhood program known as Head Start, a legacy of Lyndon Johnson's mid-1960s declaration of war on poverty.

The programs shared seven common features: they were focused on the subject areas that teachers teach; incorporated active learning; supported collaboration; used models and modeling to demonstrate effective practice; provided expert coaching and support, offered opportunities for feedback and reflection, and were sustained in duration, often unfolding over months or years, rather than occurring in a single, «drive - by» after school workshop, as is often the norm.

This funding level increase is especially noteworthy following President Trump's proposal to eliminate the program in both the FY2018 and FY2019 budget proposals, which drove friends of afterschool to reach out to Congress with more than 103,000 calls and emails since January 2017, energized supporters to turn out at town halls in their communities, and prompted more than 600 local, state, and national organizations to sign a letter in support of Community Learning Centers sent to Congress last week.

In some cases this further results in dropping technology -(rather than learner) driven programs and support.

In this series of post against the high - regulation approach to school choice, I have demonstrated that performance accountability is not typical of government programs and that heavy regulation drives away quality supply, hurting rather than protecting the students these regulations are meant to help.

In his January budget proposal, Brown called the current system «complex, state - driven and administratively costly,» and pointed out that funding for special education is a patchwork of more than 20 programs each with its own set of formulas and spending rules.

For the first time ever, I am thrilled with the offerings of a «test - prep» program because it is more than just test - prep; it is thinking prep, and thinking is what drives the processes for students to succeed.

Teachers whose preparation programs focused on the work of the classroom, provided a supervised clinical experience, and gave them the opportunity to engage in the practices of teaching were able to drive greater learning gains for their students once in the classroom than those who did not receive the same kind of clinically oriented preservice training.56 Prospective teachers who had a longer clinical experience reported greater confidence in their teaching abilities and were more likely to say that the length of time they spent as a student teacher was adequate, compared with their peers who had shorter clinical experiences.57

The state recently reported that recovery dollars have been used to provide funding for more than 3,600 education jobs from Jan. 1 to March 31, 2010, while also supporting programs that drive education reform.

The state recently reported that recovery dollars have been used to provide funding for more than 250 education jobs from April 1 to June 30, 2010, while also supporting programs that drive education reform.

«Audi doesn't program the transmission to upshift as quickly as some other companies, which is much nicer for those of us who drive a little more aggressively than the Buick we're stuck behind in traffic.»

At this point, I'm sure an automated car could be programmed drive a track faster than I can.

(source) Of course, actual fuel savings probably won't be as large for everybody as it is for me - it seems to help to live in a hilly area or drive a lot of stretches where it's downhill enough to maintain speed coasting but not with the transmission engaged, and it applies mostly to city driving - but it seems like there is still enough savings that it would more than pay for engineering time to developing an improved transmission program.

With the standard rear - biased Quattro all - wheel - drive system and launch - control program, the Spyder is just fractionally slower than its hardtop sibling (which is lighter by 220 pounds), roaring to 62 mph in 4.1 seconds and to 125 mph in 12.7 seconds.

We'd rather select our own shift points rather than program in a dynamic drive mode to do it for us.

If you know you're not going to drive more than the mileage limit in the lease program, then a lease is a great deal for you.